Photo of Marja Blom
  • PL 62 (Viikinkaari 11)

    00014

    Finland

20052017
If you made any changes in Pure these will be visible here soon.

Personal profile

Description of research and teaching

Description of research and teaching

Research Areas

312 Clinical medicines, 314 Health sciences, 317 Pharmacy

Effectiveness and cost effectiveness of hospital treatment, measuring health related quality of life, quality of life-instruments, PROs (Patient Reported Outcomes)  instruments, the impact of waiting time to the final outcomes and costs in hip and knee replacements, management of surgical care, outcomes of surgical care, cost of illness, cost of adverse events of care, surgical wound infections, patient injuries,  Health Technology Assessment, register research, RCTs, systematic reviews, meta-analysis.

Keywords

Effectiveness, Cost-Effectiveness, Cost-Utility, Health Related Quality of Life (HRQoL),  Health Technology Assessment, Systematic reviews, Meta-Analysis, Health Economics, Pharmacoeconomics

Teaching

Teacher and co-ordinator of undergraduate and postgraduate courses in Pharmaepidemiology, Pharmacoeconomics, Economic Evaluation, Health Technology Assessment, Critical Appraisal of Evidence, Measuring Effectiveness in Pharmacoeconomic Research,  Research Methods in Social Pharmacy and Pharmacoeconomics and in addition, in business economy and leadership.

Keywords

  • 317 Pharmacy
  • 314 Health sciences
  • 312 Clinical medicine

International and National Collaboration Publications and projects within past five years.

Selected Publications 2005 2017

Systematic Review and Meta-Analysis of the Efficacy and Safety of Existing TNF Blocking Agents in Treatment of Rheumatoid Arthritis

Aaltonen, K. J., Virkki, L. M., Malmivaara, A., Konttinen, Y. T., Nordström, D. C. & Blom, M., Jan 2012, In : PLoS One. 7, 1, p. Article Number: e30275 14 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

The effect of waiting time on health and quality of life outcomes and costs of medication in hip replacement patients: a randomized clinical trial

Tuominen, U., Sintonen, H., Hirvonen, J., Seitsalo, S., Paavolainen, P., Lehto, M. UK., Hietaniemi, K. & Blom, M., 2009, In : Osteoarthritis and Cartilage. 2009, 17, p. 1144-1150 7 p.

Research output: Contribution to journalArticleScientificpeer-review

Is Longer Waiting Time for Total Knee Replacement Associated with Health Outcomes and Medication Costs? Randomized Clinical Trial

Tuominen, U., Sintonen, H., Hirvonen, J., Seitsalo, S., Paavolainen, P., Lehto, M., Hietaniemi, K. & Blom, M., 2010, In : Value in Health. 13, 8, p. 998-1004 7 p.

Research output: Contribution to journalArticleScientificpeer-review

The effect of waiting time on health-related quality of life, pain, and physical function in patients awaiting primary total hip replacement: a randomized controlled trial

Hirvonen, J., Tuominen, U., Seitsalo, S., Lehto, M., Paavolainen, P., Hietaniemi, K., Rissanen, P., Sintonen, H. & Blom, M., 2009, In : Value in Health. 12, 6, p. 942-947 6 p.

Research output: Contribution to journalArticleScientificpeer-review

Measuring cost-effectiveness of secondary health care: Feasibility and potential utilization of results

Räsänen, P., Sintonen, H., Ryynänen, O-P., Blom, M., Semberg-Konttinen, V. & Roine, R. P., 2005, In : International Journal of Technology Assessment in Health Care. 21, 1, p. 22-31 10 p.

Research output: Contribution to journalArticleScientificpeer-review

Projects 2014 2016

Selected Activities 1995 2018

Finnish Pharmaceutical Pricing Board, Ministry of Social Affairs and Health (External organisation)

Marja Blom (Expert member)
1 Jan 201031 Dec 2015

Activity: Membership typesMembership or other role in public Finnish or international organization